To investigate MSN’s tumor-promoting effect on CRC via RUNX2, we silenced RUNX2 expression in MSN-overexpressing cells by transfecting shRNA against RUNX2 (RUNX2-shRNA). The gene discussed is MSN; the disease is colorectal carcinoma.